HCA Data Explorer

Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.

Updated August 28, 2023

Alzheimer's disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal entorhinal cortex and the superior frontal gyrus-brain regions where neurofibrillary inclusions and neuronal loss occur early and late in AD, respectively-from postmortem brains spanning the progression of AD-type tau neurofibrillary pathology. We identified RORB as a marker of selectively vulnerable excitatory neurons in the entorhinal cortex and subsequently validated their depletion and selective susceptibility to neurofibrillary inclusions during disease progression using quantitative neuropathological methods. We also discovered an astrocyte subpopulation, likely representing reactive astrocytes, characterized by decreased expression of genes involved in homeostatic functions. Our characterization of selectively vulnerable neurons in AD paves the way for future mechanistic studies of selective vulnerability and potential therapeutic strategies for enhancing neuronal resilience.

Lea T GrinbergMemory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CAlea.grinberg@ucsf.edu
Martin KampmannInstitute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, CAmartin.kampmann@ucsf.edu
Kun Leng1
Emmy Li1
Rana Eser2
Antonia Piergies2
Rene Sit3
Michelle Tan3
Norma Neff3
Song Hua Li2
Roberta Diehl Rodriguez4
Claudia Kimie Suemoto5
Renata Elaine Paraizo Leite5
Alexander J Ehrenberg2
Carlos A Pasqualucci5
William W Seeley2
Salvatore Spina2
Helmut Heinsen5
Lea T Grinberg6
Martin Kampmann7
1Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, CA, USA.
2Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
3Chan Zuckerberg Biohub, San Francisco, CA, USA.
4Department of Neurology, Universidade de São Paulo, Faculdade de Medicina, São Paulo, Brazil.
5Department of Pathology, Universidade de São Paulo, Faculdade de Medicina, São Paulo, Brazil.
6Memory and Aging Center, Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA
7Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, CA
Rachel Schwartz

To reference this project, please use the following link:

https://explore.data.humancellatlas.org/projects/7dcffc32-7c82-4396-9a4f-88b5579bfe8a

Supplementary links are provided by contributors and represent items such as additional data which can’t be hosted here; code that was used to analyze this data; or tools and visualizations associated with this specific dataset.

1.https://kampmannlab.ucsf.edu/ad-brain2.https://www.synapse.org/#!Synapse:syn21788402/wiki/601825
GEO Series Accessions:

Downloaded and exported data is governed by the HCA Data Release Policy and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). For more information please see our Data Use Agreement.

Analysis Portals

CZ CELLxGENECZ CELLxGENE

Project Label

Grinberg-Human-10x3pv2

Species

Homo sapiens

Sample Type

specimens

Anatomical Entity

brain

Organ Part

2 organ parts

Selected Cell Types

Unspecified

Disease Status (Specimen)

Alzheimer disease

Disease Status (Donor)

Alzheimer disease

Development Stage

human adult stage

Library Construction Method

10x 3' v2

Nucleic Acid Source

single nucleus

Paired End

false

Analysis Protocol

analysis_protocol_1

File Format

3 file formats

Cell Count Estimate

106.1k

Donor Count

10
fastq.gz60 file(s)tar1 file(s)xlsx1 file(s)